The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2022

Filed:

Jul. 07, 2017
Applicants:

Tak-circulator Co., Ltd, Tokyo, JP;

University of Tokyo, Tokyo, JP;

Inventors:

Tetsu Akiyama, Tokyo, JP;

Hiroaki Harada, Tokyo, JP;

Yusuke Yamazumi, Tokyo, JP;

Takeaki Oda, Tokyo, JP;

Oh Sasaki, Tokyo, JP;

Kazuyoshi Kofu, Tokyo, JP;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61P 11/06 (2006.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1136 (2013.01); A61P 11/06 (2018.01); C12Q 1/6883 (2013.01); G01N 33/5094 (2013.01); C12Q 2600/16 (2013.01);
Abstract

Provided are a method for screening agents for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and an agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5. A method for screening agents for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 having as the index at least one selected from the group consisting of changes in the expression of the MEX3B gene or MEX3B protein and changes in the function of the MEX3B protein.


Find Patent Forward Citations

Loading…